Skip Ribbon Commands
Skip to main content
Menu
Dr Felicia Chin Hui Xian

Dr Chin Hui Xian Felicia

MBBS (Spore), MRCOG (RCOG, UK), MMed (O&G) (Spore)

Senior Consultant

KK Women's and Children's Hospital

Specialty: Gynaecological Oncology, Obstetrics & Gynaecology

Sub-specialties: Gynaecological Oncology

Conditions Treated by this Doctor:
Adenomyosis, Cancer of the uterus, Cervical Cancer, Cervical Cancer Surgery, Chemotherapy, Cone Biopsy, Ectopic Pregnancy, Endometrial Hyperplasia, Endometrial/Cervical polyps, Endometriosis, Endometriosis and Ovarian Cysts, Fibroids, Fibroids of the uterus, Lymphoedema, Ovarian Cancer, Ovarian Cancer Surgery, Ovarian Cysts, Pap Smear Screening and Treatment for Pre-Cancer of the Cervix, Pregnancy and associated conditions, Pre-invasive Cervical Disease, Radiation Therapy, Radical Hysterectomy, Uterine Cancer, Vagina Cancer, Vulva Cancer.

Clinical Appointments

  • Senior Consultant KK Gynaecological Cancer Centre KK Women's and Children's HospitalKK Women's and Children's Hospital
  • Senior Consultant Maternity Services KK Women's and Children's HospitalKK Women's and Children's Hospital

Profile

Dr Felicia Chin Hui Xian is a Senior Consultant with the Department of Gynaecological Oncology. She graduated from the Yong Loo Lin School of Medicine, National University of Singapore, in 2008. She rotated through Anaesthesia and General Surgery, before embarking on training in Obstetrics and Gynaecology at KK Women’s and Children’s Hospital (KKH) in 2010. Dr Chin has been an accredited specialist in Obstetrics and Gynaecology since 2016, with a special interest in Gynaecological Cancer surgery.

Dr Chin was awarded the SingHealth Health Manpower Development Plan (HMDP) Award in 2019. She completed fellowship training in Fertility Sparing Management in Gynaecological Cancers at the Royal Women’s Hospital, Melbourne in 2020. In collaboration with the Department of Reproductive Medicine, she developed the Gynae Oncofertility Service in KKH, which aims to provide wholistic care for young women with cancer. In addition, Dr Chin was instrumental in implementing KKH’s Endometrial Hyperplasia Management Guidelines to standardize and streamline care for women with the condition.

For her dedication to patient care, Dr Chin was awarded the Service From The Heart Award in 2018, and the SingHealth Quality Service Silver Award in 2019. Dr Chin is a clinical tutor and examiner at the Yong Loo Lin and Lee Kong Chian Schools of Medicine, and Clinical Assistant Professor of the SingHealth Duke-NUS Obstetrics and Gynaecology Academic Clinical Programme. She is also faculty of the SingHealth PGY1 Residency Program, and was awarded the Outstanding Faculty Award at the SingHealth Residency RISE Awards 2016.

Education

  • MMed O&G (Spore) 2014
  • MRCOG (UK) 2014
  • MBBS (Spore) 2008

Professional Appointments and Committee Memberships

  • Senior Consultant, Department of Gynaecological Oncology, Division of O&G, KK Women's and Children's Hospital
  • Clinical Assistant Professor, SingHealth Duke-NUS Obstetrics and Gynaecology Academic Clinical Programme
  • Clinical Lecturer, Yong Loo Lin School of Medicine
  • Clinical Teacher, Lee Kong Chian School of Medicine
  • Member, Singapore Medical Association (SMA)
  • Member, Obstetrical & Gynaecological Society of Singapore (OGSS)
  • Member, Society for Colposcopy & Cervical Pathology of Singapore (SCCPS)
  • Member, Royal College of Obstetricians & Gynaecologists (RCOG)
  • Member, European Society of Gynaecological Oncology (ESGO)
  • Member, International Gynaecologic Cancer Society (IGCS)
  • Member, Gynaecologic Cancer Group Singapore (GCGS)

Awards

  • SingHealth Long Service Award (10 years) 2020
  • SingHealth HMDP Award – Fertility Sparing Management in Gynaecological Cancers 2019
  • SingHealth Quality Service Award – Silver 2019
  • Service from the Heart Award 2018
  • Outstanding Faculty Award Academic Year 2015/2016, SingHealth Residency RISE Awards 2016
  • International Development and Education Award Oral Presentation: Management and Outcomes of Stage 1C1 Epithelial Ovarian Carcinoma, 4th Biennial Meeting, Asian Society of Gynaecologic Oncology, Seoul 2015 
  • SingHealth Best Medical Officer Award 2014
  • SingHealth Best Medical Officer Award 2013
  • SingHealth Best Medical Officer Award 2012
  • KKH Best Medical Officer Award (O&G) 2012
  • KKH Best Medical Officer Award (O&G) 2011

Research Interests

Publications

  • Courtney E, Chan SH, Li ST, Ishak D, Merchant K, Shaw T, Chay WY, Chin FHX, Wong WL, Wong A, Ngeow J Biallelic NF1 Inactivation in High Grade Serous Ovarian Cancers from Patients with Neurofibromatosis Type 1 Fam Cancer. 2020; 10.1007/s10689-020-00184-3
  • Lim YK, Chin HX, Lin XH, Yam KL, Chia YN, et al Is Tumor Size a Predictor of Survival in Stage IIA Cervical Cancer? A Comparison Between the Old and the New FIGO Staging Criteria
  • Int J Gynecol Clin Pract. Mar 2017; 4:128
  • HX Chin, E Koh, SH Chew, SK Lim-Tan, S Sulaiman, YK Lim
    Primary Neuroendocrine Carcinoma of the Endometrium – A Case Report
    European Journal of Gynaecological Oncology, 2017, 38(5): 818-820
  • Chin HX, Tan EL, Tan LK, Ho TH
    Interstitial Implantation of the Placenta presenting with Retained Placenta after Vaginal Delivery at Term J Womens Health, Issues Care. Mar 2016; 5:3

Research Trials